GENE ONLINE|News &
Opinion
Blog

American Society of Hematology
64th ASH Annual Meeting and Exposition: Broad Coverage of Clinical, Social, and Nutritional Issues
2023-01-04
64th ASH Annual Meeting and Exposition: Standard Treatments Face Challenges
2022-12-29
ASH 2021: 4 Immunotherapies Highlight Transformations in Blood Cancer Treatment
2021-12-13
R&D
Roche Impresses with its Bispecific Antibody Portfolio for Blood Cancer Treatments
2020-12-13
R&D
Novartis’ Chronic Myeloid Leukemia Drug Demonstrates Superior Results to Pfizer’s
2020-12-10
ASH2020: VelosBio’s ROR1 Targeted Therapy Shines in Safety Trial
2020-12-09
R&D
ASH2020: New Studies Showcase Potential of CAR-T Therapy to Treat More Cancers
2020-12-07
CRISPR Gene-Edited Therapy CTX001 Raises Hopes for Sickle Cell Disease and β-Thalassemia Cures
2020-12-07
Kite Presents Yescarta’s Encouraging Long Term ZUMA-1 Trial Results at ASH2020
2020-12-06
ASH2020: Incyte Presents Positive Phase 3 Data for cGVHD Drug, Ruxolitinib
2020-12-06
uniQure’s Gene Therapy Impresses in Pivotal Trial Raising Hopes of a Hemophilia B Cure
2020-11-22
Roche Announces Analysis of Hemlibra’s Phase III HAVEN 2 Study at ASH meeting
2018-12-21
LATEST
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
Singapore’s NUS Medicine Launches Centre for Sustainable Medicine
2023-11-20
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
Scroll to Top